Finance

Lists
EWL:ETR
Edwards Lifesciences Corp
€73,54
+1,80%
(+1,30) 1D
28 Jul., 17:35:45 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EWL...
Open
€74,22
High
€74,22
Low
€73,54
Mkt. cap
48,18 mjd
Avg. vol.
121,00
Volume
1,00
52-wk high
€84,00
52-wk low
€62,00
No. of employees
16 k
Open
€74,22
High
€74,22
Low
€73,54
Mkt. cap
48,18 mjd
Avg. vol.
121,00
Volume
1,00
52-wk high
€84,00
52-wk low
€62,00
No. of employees
16 k
News stories
From sources across the web
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 k
Founded1958
HeadquartersIrvine, Kalifornië, Verenigde State van Amerika
SectorMedical device
Websiteedwards.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,55 mjd
1,57 mjd
1,65 mjd
1,74 mjd
Cost of goods sold
345,20 m
343,00 m
362,60 m
392,40 m
Cost of revenue
345,20 m
343,00 m
362,60 m
392,40 m
Research and development expenses
280,70 m
267,70 m
263,30 m
278,90 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514,60 m
601,20 m
522,20 m
561,20 m
Operating expense
782,80 m
854,60 m
771,30 m
829,10 m
Total operating expenses
1,13 mjd
1,20 mjd
1,13 mjd
1,22 mjd
Operating income
425,10 m
372,00 m
514,70 m
519,50 m
Other non operating income
1,10 m
2,30 m
69,90 m
-3,30 m
EBT including unusual items
348,40 m
90,40 m
459,00 m
519,80 m
EBT excluding unusual items
444,50 m
464,00 m
603,60 m
546,20 m
Income tax expense
56,10 m
26,20 m
78,30 m
278,40 m
Effective tax rate
16,10%
28,98%
17,06%
53,56%
Other operating expenses
-12,50 m
-14,30 m
-14,20 m
-11,00 m
Net income
291,10 m
91,20 m
380,70 m
241,90 m
Net profit margin
18,74%
5,81%
23,09%
13,89%
Earnings per share
0,67
0,58
0,78
0,78
Interest and investment income
16,70 m
114,20 m
17,40 m
30,00 m
Interest expense
-
-20,40 m
-
-
Net interest expenses
16,70 m
93,80 m
17,40 m
30,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
464,30 m
414,70 m
555,60 m
560,40 m
Gain or loss from assets sale
-
-33,90 m
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer